P0427: Nutritional factors associated with the presence of non-alcoholic fatty liver disease (NAFLD) in patients with inflammatory bowel disease (IBD)ECCO'25Year: 2025
Authors: Castelhano , N.S.(1);Oliveira , E.C.S.D.(1);Lopes , M.A.(1);Beraldo , R.F.(1);Baima , J.P.(1);Herrerias , G.S.P.(1);Quaglio , A.E.V.(2);Di Stasi , L.C.(3);Barbosa , W.F.(1);Silva , G.F.(1);Sassaki , L.Y.(1)*;
(1)São Paulo State University Unesp- Medical School, Department of Internal Medicine, Botucatu, Brazil;(2)Verum Ingredients, Botucatu Technology Park, Botucatu, Brazil;(3)São Paulo State University Unesp-Institute of Biosciences, Department of Biophysics and Pharmacology, Botucatu, Brazil;
P0428: Validation of the Urgency-Numeric Rating Scale in Ulcerative Colitis and correlation with endoscopic, histological and manometric activityECCO'25Year: 2025
Authors: Guimaraes, A.(1)*;Leal, T.(1);Caetano, A.C.(1);Barbosa, I.(2);Costa, D.(1);Carvalho, T.(1);Mendes, S.(1);Soares, J.(1);Rodrigues, Â.(1);Gonçalves, R.(1);
(1)Unidade Local de Saúde de Braga, Gastrenterology, Braga, Portugal;(2)Escola de Medicina Universidade do Minho, Gastrenterology, Braga, Portugal;
P0429: Endocytoscopy in real-time assessment of histological and endoscopic activity in ulcerative colitisECCO'25Year: 2025
Authors: Chaemsupaphan, T.(1,2)*;Ali, M.S.(1);Paramsothy, S.(1,3);Leong, R.W.(1,3);
(1)Concord Repatriation General Hospital, Gastroenterology and Liver Services, Sydney, Australia;(2)Siriraj Hospital Mahidol University, Gastroenterology, Bangkok, Thailand;(3)University of Sydney, Faculty of Medicine and Health, Sydney, Australia;
P0430: Central reading of ulcerative colitis endoscopic disease activity: Automated but with a human in the loop (2M+1H)ECCO'25Year: 2025
Authors: Battioui, C.(1);Gottlieb, K.(1)*;Wang, Y.(2);Brodskiy, P.(3);Haft-Javaherian, M.(3);Colucci, D.(2);Thomason, D.(2);Baxi, S.(2);
(1)Eli Lilly & Company, Clinical Research, Indianapolis, United States;(2)Iterative Health- Inc., Data & Insights, Cambridge, United States;(3)Iterative Health- Inc., Machine Learning, Cambridge, United States;
Food and Drug Administration. Ulcerative Colitis: Developing Drugs for Treatment [Internet]. 2022 [cited 2024 Oct 17]. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/ulcerative-colitis-developing-drugs-treatment
Gottlieb, K., Daperno, M., Usiskin, K., Sands, B. E., Ahmad, H., Howden, C. W., . . . & Reinisch, W. (2021). Endoscopy and central reading in inflammatory bowel disease clinical trials: Achievements, challenges and future developments. Gut, 70(2), 418-426.
Rimondi, A., Gottlieb, K., Despott, E. J., Iacucci, M., Murino, A., & Tontini, G. E. (2023). Can artificial intelligence replace endoscopists when assessing mucosal healing in ulcerative colitis? A systematic review and diagnostic test accuracy meta-analysis. Digestive and Liver Disease, 56(7):1164-1172.
Cohen, I. G., Babic, B., Gerke, S., Xia, Q., Evgeniou, T., & Wertenbroch, K. (2023). How AI can learn from the law: Putting humans in the loop only on appeal. npj Digital Medicine, 6(1), 160.
P0431: Multiparametric Assessment of IBD, SpA and IBD-SpA patients to explore disease biomarkers and response predictorsECCO'25Year: 2025
Authors: Parisio, L.(1)*;Privitera, G.(2);Varca, S.(3);Perniola, S.(4);Alivernini, S.(4);Tolusso, B.(4);Petito, V.(5);Masi, L.(5);Napolitano, D.(1);Schiavoni, E.(1);Turchini, L.(1);Amatucci, V.(1);Scaldaferri, F.(6);Gasbarrini, A.(7);Armuzzi, A.(8);Gremese, E.(9);Guidi, L.(1);Pugliese, D.(10);
(1)Fondazione Policlinico A.Gemelli IRCCS, IBD Unit- Digestive Disease Center CeMAD- Dipartimento di Scienze Mediche e Chirurgiche, Rome, Italy;(2)Università degli studi di Milano, Internal Medicine, Milano, Italy;(3)Fondazione Policlinico A.Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy;(4)Fondazione Policlinico A.Gemelli IRCCS, Immunology Research Core Facility Gemelli Science and Technology Park GSTeP, Rome, Italy;(5)Fondazione Policlinico A.Gemelli IRCCS, CeMAD Translational Research Laboratories- Digestive Disease Center CeMAD- Dipartimento di Scienze Mediche e Chirurgiche, Rome, Italy;(6)Fondazione Policlinico A.Gemelli IRCCS, IBD Unit- CeMAD Translational Research Laboratories- Digestive Disease Center CeMAD- Dipartimento di Scienze Mediche e Chirurgiche- Dipartimento di Medicina e Chirurgia Traslazionale- Università Cattolica del Sacro Cuore, Rome, Italy;(7)Fondazione Policlinico A.Gemelli IRCCS, UOC Medicina Interna e Gastroenterologica- Digestive Disease Center CeMAD- Dipartimento di Scienze Mediche e Chirurgiche- Dipartimento di Medicina e Chirurgia Traslazionale- Università Cattolica del Sacro Cuore, Rome, Italy;(8)Humanitas Clinical and Research Center IRCCS, Gastroenterology, Milan, Italy;(9)Humanitas Clinical and Research Center IRCCS, Reumatology, Milan, Italy;(10)Fondazione Policlinico A.Gemelli IRCCS, UOS Gastroenterologia Ospedale Isola Tiberina Gemelli Isola- IBD Unit- Digestive Disease Center CeMAD- Dipartimento di Scienze Mediche e Chirurgiche- Dipartimento di Medicina e Chirurgia Traslazionale- Università Cattolica del Sacro Cuore, Rome, Italy;
P0432: CMV infection in IBD patients with disease flare in the era of advanced therapies and outpatient settingECCO'25Year: 2025
Authors: Pipek, B.(1)*;Zelinková, Z.(2);
(1)University Hospital and Faculty of Medicine and Dentistry Palacky University Olomouc, Department of Internal Medicine II-gastroenterology and geriatrics, Ostrava, Czech Republic;(2)Penta Hospitals Bory Bratislava, Department of gastroenterology, Bratislava, Slovakia;
Maresca, R et al. Cytomegalovirus Infection: An Underrated Target in Inflammatory Bowel Disease Treatment. J. Clin. Med. 2024, 13, 136
P0433: Pouchitis described by the SES-CD score is more associated with the need for biologics initiation after IPAA than endoscopic subscore of PDAIECCO'25Year: 2025
Authors: Simonič, J.(1)*;Simonič, P.(1);Bislenghi, G.(2);D’Hoore, A.(2);Verstockt, B.(1,3);Ferrante, M.(1,3);Vermeire, S.(1,3);Sabino, J.(1,3);
(1)KU Leuven, Department of Chronic Diseases and Metabolism, Leuven, Belgium;(2)University Hospitals Leuven, Department of Abdominal Surgery, Leuven, Belgium;(3)University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;
References
(1) Jairath V, Feagan BG, Silverberg MS, et al. Mucosal healing with vedolizumab in patients with chronic pouchitis: EARNEST, a randomized, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol. Published online 2024. doi: 10.1016/j.cgh.2024.06.037
(2) Sedano R, Nguyen TM, Almradi A, et al. Disease activity indices for pouchitis: A systematic review. Inflamm Bowel Dis. 2022;28(4):622-638. doi:10.1093/ibd/izab124
(3) Barnes EL, Long MD, Raffals L, et al. Development of the endoscopic pouch score for assessment of inflammatory conditions of the pouch. Clin Gastroenterol Hepatol. 2023;21(6):1663-1666.e3. doi: 10.1016/j.cgh.2022.04.026
P0434: Clinical patterns and prognosis according to the time of diagnosis in Korean IBD Patients with over 10 years of disease durationECCO'25Year: 2025
Authors: Park, Y.E.(1);Park, S.B.(2)*;Kang, S.B.(3);Park, Y.(4);Kim, D.(5);Na, S.Y.(6);Moon, W.(7);
(1)Inje University School of Medicine- Haeundae Paik Hospital, Division of Gastroenterology- Department of Internal Medicine, Busan, Korea- Republic Of;(2)Pusan National University School of Medicine and Research Institute for Convergence of Biomedical Science and Technology- Pusan National University Yangsan Hospital- Yangsan, Department of Internal Medicine, Busan, Korea- Republic Of;(3)Daejeon St. Mary's Hospital- College of Medicine- the Catholic University of Korea, Division of Gastroenterology- Department of Internal Medicine, Daejeon, Korea- Republic Of;(4)Ewha Womans University Seoul Hospital, Department of Internal Medicine, Seoul, Korea- Republic Of;(5)Konyang University College of Medicine, Department of Internal Medicine, Daejeon, Korea- Republic Of;(6)Incheon St. Mary’s Hospital- College of Medicine- The Catholic University of Korea, Division of Gastroenterology- Department of Internal Medicine, Incheon, Korea- Republic Of;(7)Kosin University School of Medicine, Department of Internal Medicine, Busan, Korea- Republic Of; IBD Research Group of the Korean Association for the Study of Intestinal Diseases (KASID)
1. Thia KT, Loftus EV, Jr., Sandborn WJ, Yang SK (2008) An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol 103(12):3167-3182.2. Duricova D, Burisch J, Jess T, et al. Age-related differences in presentation and course of pediatric inflammatory bowel disease; an update on the populationbased literature. J Crohns Colitis 2014;8(11):1351–61. 5.3. Carroll MW, Kuenzig ME, Mack DR, et al. The impact of inflammatory bowel disease in Canada 2018: children and adolescents with IBD. J Can Assoc Gastroenterol 2019;2:S49–S67.
P0435: Comparative analysis between capsule endoscopy and ileocolonoscopy for activity detection in ileal Crohn's disease. Preliminary results from the CAPITER study, a multicenter study from the Young Group of GETECCU.ECCO'25Year: 2025
Authors: Marquès-Camí, M.(1)*;Vergés, L.(1);Caballero-Mateos, A.M.(2);Carvaca, C.(3);Suárez-Ferrer, C.(4);Carballo-Folgoso, L.(5);Carballal, A.(6);Roig, C.(7);Fernández-Clotet, A.(8);Moreno, V.(9);Tejido, C.(10);Brunet-Mas, E.(11);Torres, G.(12);Huguet, J.M.(13);San-Román, C.(14);Benítez, J.M.(15);Zabana, Y.(16);
(1)Hospital Universitari Arnau de Vilanova and Institut de Recerca Biomèdica de Lleida IRBLleida, Gastroenterology, Lleida, Spain;(2)Hospital Santa Ana, Gastroenterology, Motril, Spain;(3)Hospital Gómez Ulla, Gastroenterology, Madrid, Spain;(4)Hospital Universitario La Paz, Gastroenterology, Madrid, Spain;(5)Hospital Universitario Central de Asturias, Gastroenterology, Oviedo, Spain;(6)Hospital Universitario de Cabueñes, Gastroenterology, Gijón, Spain;(7)Hospital de la Santa Creu i Sant Pau, Gastroenterology, Barcelona, Spain;(8)Hospital Clinic, Gastroenterology, Barcelona, Spain;(9)Hospital General Universitario Dr Balmis, Gastroenterology, Alicante, Spain;(10)Complejo Hospitalario Universitario de Ourense, Gastroenterology, Ourense, Spain;(11)Hospital Parc Taulí and Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas CIBERehd, Gastroenterology, Sabadell, Spain;(12)Hospital General de Granollers, Gastroenterology, Granollers, Spain;(13)Hospital General Universitario de Valencia, Gastroenterology, Valencia, Spain;(14)Hospital Universitario de Toledo, Gastroenterology, Toledo, Spain;(15)Hospital Universitario Reina Sofía, Gastroenterology, Córdoba, Spain;(16)Hospital Universitari Mútua de Terrassa and Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas CIBERehd, Gastroenterology, Terrassa, Spain; On behalf of the Young Group of GETECCU
P0437: Positive anti-Saccharomyces cerevisiae antibodies do not affect clinical outcomes in pediatric patients with Crohn's disease treated with anti-TNF therapyECCO'25Year: 2025
Authors: LIng, D.(1);Grabovski, R.(1);Matar, M.(2);Shamir, R.(2);Shouval , D.S.(2);Weintraub, Y.(2)*;
(1)Tel Aviv University, Faculty of Medicine, Tel Aviv, Israel;(2)Schneider Children's Medical Center, Institute of Gastroenterology- Nutrition and Liver Diseases, Petach Tikva, Israel;
P0438: Altered Visceral Sensitivity in patients with Ulcerative Colitis in remission.ECCO'25Year: 2025
Authors: Trikola, A.(1)*;Mylonas, I.(1);Gerasimos , S.(2);Viazis, N.(1);
(1)Evangelismos General Hospital, Gastroenterology Department, Athens, Greece;(2)Athens Naval Hospital, Gastroenterology Department, Athens, Greece;
P0439: Ultrasound transmural healing reduces the risk of relapse in Crohn’s disease patients with endoscopic mucosal healing: results of a prospective studyECCO'25Year: 2025
Authors: Yzet, C.(1)*;Brazier, F.(1);Derval, E.(1);Pricope, D.(2);Vaneslander, P.(3);Dejour, V.(3);Diouf, M.(4);Ollier, A.(4);Fumery, M.(1);
(1)Amiens university hospital, Gastroenterology, Amiens, France;(2)Compiegne Hospital, Gastroenterology, Compiègne, France;(3)Clinique Saint Claude, Gastroenterology, Saint Quentin, France;(4)Amiens university hospital, biostatistic, Amiens, France;
P0440: Faecal and plasma zinc as predictors of relapse in quiescent Crohn’s Disease in the Stratifying Crohn’s Using Biomarker Assessment (SCUBA) studyECCO'25Year: 2025
Authors: Palmer, J.(1)*;Catchpole, A.(2);Talwar, D.(2);Veryan, J.(3);Colbert, R.(1);Seenan, J.P.(4);Macdonald, J.(4);Gerasimidis , K.(5);Gaya, D.R.(1);
(1)Glasgow Royal Infirmary, Gastroenterology, Glasgow, United Kingdom;(2)Glasgow Royal Infirmary, Biochemistry, Glasgow, United Kingdom;(3)University Hospital Monklands, Gastroenterology, Glasgow, United Kingdom;(4)Queen Elizabeth University Hospital, Gastroenterology, Glasgow, United Kingdom;(5)University of Glasgow, Clinical Nutrition, Glasgow, United Kingdom;
1 Siva S, Rubin DT, Gulotta G, Wroblewski K, Pekow J. Zinc Deficiency is Associated with Poor Clinical Outcomes in Patients with Inflammatory Bowel Disease. Inflammatory bowel diseases. 2017 Jan;23(1)doi:10.1097/MIB.0000000000000989
2 MJ M, S D, C T, et al. A prospective analysis of micronutrient status in quiescent inflammatory bowel disease - PubMed. Clinical nutrition (Edinburgh, Scotland). 2021 Jan;40(1)doi:10.1016/j.clnu.2020.05.010
P0441: Vitamin D seasonal fluctuation is more prominent in inflammatory bowel disease patients undergoing advanced therapiesECCO'25Year: 2025
Authors: Baz-Lopez, A.(1)*;Baston-Rey, I.(2);Marti-Marques , E.(1);Calviño-Suarez, C.(2);Santos-Blanco, E.(1);Ferreiro-Iglesias, R.(2);Blanco-Hortas, A.(3);Lopez-Roses, L.(1);Dominguez-Muñoz, J.E.(2);Barreiro-de Acosta, M.(2);
(1)Hospital Universitario Lucus Augusti, Gastroenterology Department, Lugo, Spain;(2)University Hospital Santiago De Compostela CHUS, Department of Gastroenterology- IBD Unit, Santiago De Compostela, Spain;(3)IDIS, Research Institute, Lugo, Spain;
P0442: Prevalence and Impact of E-cigarettes on Disease Outcomes in Patients with Inflammatory Bowel DiseaseECCO'25Year: 2025
Authors: Almuhaya, H.(1)*;Alashkar, R.(2);Alsebaai, D.(2);Albadawi , N.(1);Almutairdi, A.(1);Attamimi, M.(1);Desai, S.(3);Al-Bawardy, B.(1);
(1)King Faisal Specialist Hospital & Research Centre, Department of Internal Medicine- Division of Gastroenterology and Hepatology, Riyadh, Saudi Arabia;(2)Alfaisal University, Alfaisal University, Riyadh, Saudi Arabia;(3)King Faisal Specialist Hospital & Research Centre, Department of Biostatistics- Epidemiology and Scientific Computing, Riyadh, Saudi Arabia;
P0443: Prognosis of primary sclerosing cholangitis (PSC) in Hungary is independent of coexisting inflammatory bowel disease (IBD) and prognostic ability of the currently used PSC risk scores are limitedECCO'25Year: 2025
Authors: Vén, P.(1);Lénárt, Á.(2)*;Tornai, D.(3);Tóth, B.(3);Vitális, Z.(3);Tornai, I.(3);Tornai, T.(4);Altorjay , I.(3);Papp, M.(3);
(1)University of Pécs, Division of Gastroenterology- First Department of Medicine, Pécs, Hungary;(2)University of Debrecen, Gastroenterology, Debrecen, Hungary;(3)University of Debrecen, Division of Gastroenterology- Department of Internal Medicine- Faculty of Medicine, Debrecen, Hungary;(4)Semmelweis University, Institute of Pancreatic Diseases, Budapest, Hungary;
P0444: Frequency and Characteristics of Anorectal Pathologies in Patients with Inflammatory Bowel DiseaseECCO'25Year: 2025
Authors: Contreras Aviles, E.(1)*;Philippe Ponce, M.(1);Guinea Lagunes, A.(1);Almeida del Prado, G.(1);Sebastian Ocampo , V.(1); López Perez, R.(1);Jiménez Bobadilla, B.(2);De Leon Rendon, J.L.(3);
(1)Coloproctology Service of Hospital General de México ´´Dr. Eduardo Liceaga´´, Inflammatory Bowel Disease Clinic, Ciudad de México, Mexico;(2)Coloproctology Service of Hospital General de México ´´Dr. Eduardo Liceaga´´, Coloproctology Service, Ciudad de México, Mexico;(3)Coloproctology Service of Hospital General de Méxco ´´Dr. Eduardo Liceaga´´, Clínica de Enfermedad Inflamatoria Intestinal, Mexico, Mexico;
Misselwitz B, Rickenbacher A, Brand S. Klinik, Diagnostik und Therapie proktologischer Beschwerden bei Patienten mit chronisch entzündlichen Darmerkrankungen. Therapeutische Umschau. Revue therapeutique. 2021;78(9):547-558. [citado 2024 Aug 29]. Disponible en: https://doi.org/10.1024/0040-5930/a001309 Truong A, Zaghiyan K, Fleshner P. Anorectal Crohn’s Disease. Surg Clin North Am. 2019;99(6):1151-1162. [citado 2024 Aug 29]. Disponible en: https://doi.org/10.1016/j.suc.2019.08.012 D'Ugo S, Stasi E, Gaspari AL, Sileri P. Hemorrhoids and anal fissures in inflammatory bowel disease. Minerva Gastroenterol Dietol. 2015;61(4):223-233. Hamzaoglu I, Hodin RA. Perianal problems in patients with ulcerative colitis. Inflamm Bowel Dis. 2005;11(9):856-859. [citado 2024 Aug 29]. Disponible en: https://doi.org/10.1097/01.mib.0000174373.75977.b9 Xu S, Zhang L, Li Z, et al. Enhancing surgical precision: unveiling the impact of preoperative colonoscopy in anal fistula patients. BMC Gastroenterol. 2023;23:442. [citado 2024 Aug 29]. Disponible en: https://doi.org/10.1186/s12876-023-03066-x Yamamoto T, Allan RN, Keighley MR. Effect of fecal diversion alone on perianal Crohn's disease. World J Surg. 2000;24(10):1258-1263. [citado 2024 Aug 29]. Disponible en: https://doi.org/10.1007/s002680010250 Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN, Kamm MA, Korzenik JR, Lashner BA, Onken JE, Rachmilewitz D, Rutgeerts P, Wild G, Wolf DC, Marsters PA, Travers SB, Blank MA, van Deventer SJ. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med. 2004;350(9):876-885. [citado 2024 Aug 29]. Disponible en: https://doi.org/10.1056/NEJMoa030815 Márquez Velásquez JR, González Awique PS, Miranda Ruíz CA, Muñoz Zuluaga M, Miranda Ruíz LF. Uso de la anoscopia de alta resolución para la detección de displasia anal por papilomavirus en pacientes con enfermedad inflamatoria intestinal. Rev Colomb Gastroenterol. 2023;38(4):419-2. [citado 2024 Aug 29]. Disponible en: https://revistagastrocol.com/index.php/rcg/article/view/1048 El-Gazzaz G, Hull T, Church JM. Biological immunomodulators improve the healing rate in surgically treated perianal Crohn's fistulas. Colorectal Dis. 2012;14(10):1217-1223. [citado 2024 Aug 29]. Disponible en: https://doi.org/10.1111/j.1463-1318.2012.02944.x Gold SL, Cohen-Mekelburg S, Schneider Y, Steinlauf A. Perianal fistulas in patients with Crohn's disease, part 1: current medical management. Gastroenterol Hepatol (N Y). 2018;14(8):470-481. Smith RK, Paulson EC. Perianal fistulas in patients with inflammatory bowel disease. Semin Colon Rectal Surg. 2014;25(4):216-220.
P0445: High risk of colorectal cancer after high-grade dysplasia in Inflammatory Bowel Disease patientsECCO'25Year: 2025
Authors: DerksEduarda Wilhelmina, M.(1)*;te Groen, M.(1);Derikx, L.(2);Nagtegaal, I.(3);Hoentjen, F.(4);
(1)Radboud University Medical Center, Department of Gastroenterology, Nijmegen, The Netherlands;(2)Erasmus Medical Center, Department of Gastroenterology, Rotterdam, The Netherlands;(3)Radboud University Medical Center, Department of Pathology, Nijmegen, The Netherlands;(4)University of Alberta, Division of Gastroenterology- Department of Medicine, Edmonton, Canada;
1. Choi CH, Rutter MD, Askari A, et al. Forty-Year Analysis of Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis: An Updated Overview. Am J Gastroenterol. Jul 2015;110(7):1022-34. doi:10.1038/ajg.2015.65
2. Mooiweer E, van der Meulen-de Jong AE, Ponsioen CY, et al. Incidence of Interval Colorectal Cancer Among Inflammatory Bowel Disease Patients Undergoing Regular Colonoscopic Surveillance. Clin Gastroenterol Hepatol. Sep 2015;13(9):1656-61. doi:10.1016/j.cgh.2015.04.183
3. Shah SC, Ten Hove JR, Castaneda D, et al. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. Jul 2018;16(7):1106-1113 e3. doi:10.1016/j.cgh.2018.01.023
4. Singh K, Al Khoury A, Kurti Z, et al. High Adherence to Surveillance Guidelines in Inflammatory Bowel Disease Patients Results in Low Colorectal Cancer and Dysplasia Rates, While Rates of Dysplasia are Low Before the Suggested Onset of Surveillance. J Crohns Colitis. Sep 27 2019;13(10):1343-1350. doi:10.1093/ecco-jcc/jjz066
P0446: Increased risk of venous thromboembolism post hospital discharge in patients with Inflammatory Bowel Disease: a systematic review and meta-analysisECCO'25Year: 2025
Authors: Subhaharan, D.(1)*;Zaka, A.(2);Mridha, N.(3);Haig, A.(1);Mohsen, W.(1);Kakkadasam Ramaswamy, P.(1);
(1)Gold Coast University Hospital, Department of Digestive Health, Gold Coast, Australia;(2)Gold Coast University Hospital, Department of Cardiology, Gold Coast, Australia;(3)Prince Charles Hospital, Department of Cardiology, Brisbane, Australia;
